Gordon Murdo's Insider Trades & SAST Disclosures
Gordon Murdo's most recent trade in AMGEN Inc. was a trade of 25,334 Nqso (Right to Buy) done . Disclosure was reported to the exchange on May 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gordon Murdo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 25,334 | 25,334 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 3,919 | 49,985 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 283.78 per share. | 02 May 2025 | 780 | 46,806 (0%) | 0% | 283.8 | 221,348 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 283.78 per share. | 02 May 2025 | 740 | 46,066 (0%) | 0% | 283.8 | 209,997 | Common Stock |
| AMGEN Inc. | Gordon Murdo | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 288.56 per share. | 30 Apr 2025 | 800 | 47,586 (0%) | 0% | 288.6 | 230,848 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.71 per share. | 17 Mar 2025 | 4,039 | 48,386 (0%) | 0% | 313.7 | 1,267,075 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 8,085 | 52,271 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Sale of securities on an exchange or to another person at price $ 294.79 per share. | 11 Feb 2025 | 8,771 | 44,186 (0%) | 0% | 294.8 | 2,585,644 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 22,930 | 45,860 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 3,529 | 52,674 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.29 per share. | 05 May 2024 | 665 | 49,145 (0%) | 0% | 311.3 | 207,008 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.37 per share. | 02 May 2024 | 758 | 49,810 (0%) | 0% | 277.4 | 210,246 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.38 per share. | 30 Apr 2024 | 753 | 50,568 (0%) | 0% | 276.4 | 208,114 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 268.87 per share. | 18 Mar 2024 | 6,461 | 51,321 (0%) | 0% | 268.9 | 1,737,169 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 12,924 | 57,569 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Sale of securities on an exchange or to another person at price $ 262.43 per share. | 10 Aug 2023 | 9,558 | 44,308 (0%) | 0% | 262.4 | 2,508,306 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.89 per share. | 05 May 2023 | 623 | 53,866 (0%) | 0% | 231.9 | 144,467 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 35,833 | 35,833 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,237 | 55,348 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.97 per share. | 02 May 2023 | 859 | 54,489 (0%) | 0% | 236.0 | 202,698 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.74 per share. | 30 Apr 2023 | 728 | 51,111 (0%) | 0% | 239.7 | 174,531 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP, Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 234.57 per share. | 17 Mar 2023 | 3,978 | 51,839 (0%) | 0% | 234.6 | 933,119 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 7,947 | 55,621 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2022 | 400 | 47,484 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.10 per share. | 05 May 2022 | 603 | 47,784 (0%) | 0% | 236.1 | 142,368 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 35,352 | 70,704 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 4,330 | 49,195 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 230.92 per share. | 02 May 2022 | 808 | 48,387 (0%) | 0% | 230.9 | 186,583 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.86 per share. | 18 Mar 2022 | 4,995 | 44,865 (0%) | 0% | 235.9 | 1,178,121 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 9,989 | 49,682 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 36,231 | 36,231 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,172 | 45,630 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.64 per share. | 30 Apr 2021 | 782 | 44,848 (0%) | 0% | 239.6 | 187,398 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.42 per share. | 19 Mar 2021 | 8,989 | 41,458 (0%) | 0% | 244.4 | 2,197,091 | Common Stock |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 17,989 | 50,159 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Murdo Gordon | EVP Global Commercial Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.94 per share. | 02 Nov 2020 | 6,269 | 32,036 (0%) | 0% | 216.9 | 1,359,997 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges